image image
4DBio Drug-screening Platforms

As the cost of drug development rises there is increasing need for more predictive in vitro models for drug discovery and testing. Identifying better lead compounds has the potential to improve the efficiency of drug development.

4Design Biosciences is working in collaboration with pharmaceutical and biotech companies to co-develop application-specific drug-screening platforms that more closely mimic living human tissues than do traditional methods.

Vascularized micro-organ (VMO) platform chips

Our scientists have pioneered the development of high-throughput microfluidic devices for multiple physiologically-relevant 3D human micro-organ systems that receive nutrients and drugs through living blood vessels, just as tissues do in the body.

Collaboration Opportunities

4DBio will work with you to design and develop a VMO chip customized for your purpose.

image image